ASSESSMENT OF DNA DAMAGE USING CHROMOSOMAL ABERRATIONS ASSAY IN LYMPHOCYTES OF WATERPIPE SMOKERS

Por ALSATARI, ENAS S., AZAB, MOHAMMAD, KHABOUR, OMAR F., ALZOUBI, KAREM H., SADIQ, MAY F.
Publicado em 2012

Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment

Por Covre, Alessia, Parisi, Giulia, Nicolay, Hugues JMG, Fazio, Carolina, Fonsatti, Ester, Fratta, Elisabetta, Sigalotti, Luca, Taverna, Pietro, Choy, Gavin, Azab, Mohammad, Coral, Sandra, Maio, Michele
Publicado em 2013

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

Por Jueliger, Simone, Lyons, John, Cannito, Sara, Pata, Illar, Pata, Pille, Shkolnaya, Marianna, Lo Re, Oriana, Peyrou, Marion, Villarroya, Francesc, Pazienza, Valerio, Rappa, Francesca, Cappello, Francesco, Azab, Mohammad, Taverna, Pietro, Vinciguerra, Manlio
Publicado no Epigenetics (2016)

Inhibition of HSP90 by AT13387 Delays the Emergence of Resistance to BRAF Inhibitors and Overcomes Resistance to dual BRAF and MEK Inhibition in Melanoma Models

Por Smyth, Tomoko, Paraiso, Kim H T, Hearn, Keisha, Rodriguez-Lopez, Ana M, Munck, Joanne M, Haarberg, H Eirik, Sondak, Vernon K, Thompson, Neil T, Azab, Mohammad, Lyons, John F, Smalley, Keiran S M, Wallis, Nicola G
Publicado no Mol Cancer Ther (2014)

The novel, small molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer

Por Fang, Fang, Munck, Joanne, Tang, Jessica, Taverna, Pietro, Wang, Yinu, Miller, David F.B., Pilrose, Jay, Choy, Gavin, Azab, Mohammad, Pawelczak, Katherine S., VanderVere-Carozza, Pamela, Wagner, Michael, Lyons, John, Matei, Daniela, Turchi, John J., Nephew, Kenneth P.
Publicado no Clin Cancer Res (2014)